The timing of the FDA release during trading hours on the last date to obtain a lead for the class action lawsuit and when other countries are seriously looking at the drug makes their release rather suspect.
Frankly, IMHO, it warrants a full Congressional Investigation under oath of not only Woodcock, but also the underlings that sent this out.
Something smells rotten and corrupt here.